Next Announcement, page-69

And this bit from the Annual Report on the SAMPLE PRE TREATMENT opportunity

10 billion sample tubes coated with Mixngo - Now that would be a big opportunity - perhaps need a factory with some spare capacity??...

"Stakeholders" - Is this a big Joint Venture opportunity for Anteo with some mega heavyweights?

"In April, Anteo announced that a patent filing in the area of bioseparations, a process important to the growing immunoassay market, which is expected to be valued at $19.1 billion in 2018. The patent centred on what is now an unmet clinical need: currently ~10 billion immunoassays run each year in the world are susceptible to sample-specific interference that can result in erroneous test results and unfavourable patient outcomes. Our patent centres around the provision of an automatable and effective sample pre-treatment that mitigates interference without impacting laboratory workflow or changing the sample composition. Given the size of the immunoassay market and the health and financial impact of incorrect results, the Mix&Go-based serum depletion patent has the potential to change the way immunoassays are performed across the world. So far, feedback on the concept has been strong, and we are progressing this opportunity by creating a consortium of stakeholders across the entire value chain.